Inactive Instrument

Aroa Biosurgery Limited Australian S.E.

Equities

ARX

AU0000094146

Medical Equipment, Supplies & Distribution

Aroa Biosurgery Limited Announces Preliminary Unaudited Sales Results for the First Half of Fiscal Year 2022

October 05, 2021 at 05:21 pm EDT

Aroa Biosurgery Limited announces preliminary unaudited sales results for the first half of fiscal year 2022. For the period, the company reported product sales revenue of approximately NZD 17 million.

Latest news about Aroa Biosurgery Limited

Transcript : Aroa Biosurgery Limited, Q3 2024 Earnings Call, Jan 30, 2024	Jan. 29
Aroa Biosurgery Turns to Profit in Fiscal H1	22-11-29	MT
Aroa Biosurgery Says ENIVO System Showed Potential in Reduction of Post-Surgical Complication	22-10-18	MT
Aroa Biosurgery Fiscal Q1 Cash Receipts Rise, Maintains FY23 Product Revenue Guidance	22-07-26	MT

Chart Aroa Biosurgery Limited

Duration

Period

More charts

Company Profile

Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that is the building block for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM for soft tissue repair, reinforcement and complex wounds. Its subsidiaries are Aroa Biosurgery Incorporated and Mesynthes Nominee Limited.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-20 - Q4 2024 Earnings Release (Projected)

More about the company

Sector Medical Supplies

	1st Jan change	Capi.
COLOPLAST A/S	+11.84%	27.91B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-32.98%	2.95B
WINNER MEDICAL CO., LTD.	-15.97%	2.47B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+11.90%	2.22B
HARTALEGA HOLDINGS	-1.11%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-13.37%	1.84B
TOP GLOVE CORPORATION BHD.	-7.78%	1.4B
NAKANISHI INC.	-0.38%	1.26B
KOSSAN RUBBER INDUSTRIES	+13.51%	1.13B

Medical Supplies